Healthtech’s (HLTT) Mediscan Ultrasound Diagnost
Post# of 26
(Total Views: 203)
Posted On: 03/22/2021 6:20:45 PM
Healthtech’s (HLTT) Mediscan Ultrasound Diagnostic Could Benefit Emerging Problem of COVID “Long Haulers”
- COVID-19 patients can suffer from bevy of ailments from fatigue to cardiac conditions long after virus has left their body
- Follow-up monitoring is not convenient or cost effective
- Mediscan, subsidiary of Healthtech Solutions, has brought to market a solution that has potential to become standard of care, including helping emerging “long hauler” crisis
- Mediscan’s technology converts two-dimensional ultrasound images into 3D, high-definition format in under one minute for immediate attention at point of care
Call them “long haulers” or people with “long COVID” or any other number of names, but don’t call anyone “recovered” even though coronavirus free. There is a growing chorus of patient voices and published studies suggesting at least half (and potentially up to 80%) of COVID-19 patients continue to exhibit troublesome symptoms that affect their quality of life long after tests show no viral load present (https://nnw.fm/ZNCF1). While all too often dismissed by physicians, awareness of the chronic symptoms has earned the attention of the National Institutes of Health, which has proposed “post-acute sequelae of SARS-CoV-2 infection (‘PASC’)” as an all-encompassing name for the malady.
Symptoms can range from chronic fatigue to cardiac conditions, highlighting the need for widespread adoption of simple and fast standards of care to monitor organs and tissue to best understand a patient’s condition. That’s exactly what upstart Mediscan Inc., a subsidiary of Healthtech Solutions (OTC: HLTT), is bringing to the table with its innovative software application that converts two-dimensional ultrasound images into a 3D, high-definition format in under one minute for immediate attention at the point of care.
Mediscan is bridging a big gap in healthcare today where access to magnetic resonance imaging (“MRI”) and computed tomography (CT or CAT) machines often aren’t readily available, much less convenient for immediate care. The poignant fact is that many of those facilities try to avoid even having COVID-positive patients on site—that goes without mentioning the high costs for those tests. An MRI in the U.S. in 2019 averaged $2,611, according to GE Healthcare citing Time Magazine (https://nnw.fm/lH7xB). CT scans can cost up to $3,275 (www.NewChoiceHealth.com).
Mediscan is looking to disrupt the $134 billion U.S. medical imaging market (https://nnw.fm/1eW20) with its cloud-based software that reconstructs an ultrasound’s analog 2D grayscale image into digital 3D HD format nearly instantly. For the first time, medical professionals will have at their fingertips images containing data-driven metrics that previously were only available through X-rays or MRI and CT scans. A video discussing the technology is available for viewing online (https://nnw.fm/u0r44).
Applications abound for the user-friendly technology, including a physician’s office, sporting facilities and events, isolation wards, emergency rooms and on-location for emergency medical services (“EMS”) personnel, to name a few. Anywhere an internet signal can be used – which is nearly everywhere anymore thanks to hot spots – once certified, the Mediscan technology will be able to provide almost immediate, actionable information on heart, lungs, tendons, skin and other organs. Furthermore, the Mediscan app integrates with all the popular electronic medical record (“EMR”) systems for comprehensive record keeping.
An opportunity is present for market penetration by utilizing the technology for PASC with any of the nearly 30 million Americans diagnosed with COVID-19 for an easy point-of-care diagnostic that is reliable and repeatable to track progression or regression without the inconvenience and high cost of legacy technologies. Once in the doctor’s office and other locations, it’s hard to imagine Mediscan not becoming an integral part of patient care, where a doctor or nurse could say, “Let’s take a closer look” and have data in a matter of minutes using only a portable ultrasound device and the Mediscan app.
For more information, visit the company’s website at www.MyMediScan.com.
NOTE TO INVESTORS: The latest news and updates relating to HLTT are available in the company’s newsroom at https://nnw.fm/HLTT
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- COVID-19 patients can suffer from bevy of ailments from fatigue to cardiac conditions long after virus has left their body
- Follow-up monitoring is not convenient or cost effective
- Mediscan, subsidiary of Healthtech Solutions, has brought to market a solution that has potential to become standard of care, including helping emerging “long hauler” crisis
- Mediscan’s technology converts two-dimensional ultrasound images into 3D, high-definition format in under one minute for immediate attention at point of care
Call them “long haulers” or people with “long COVID” or any other number of names, but don’t call anyone “recovered” even though coronavirus free. There is a growing chorus of patient voices and published studies suggesting at least half (and potentially up to 80%) of COVID-19 patients continue to exhibit troublesome symptoms that affect their quality of life long after tests show no viral load present (https://nnw.fm/ZNCF1). While all too often dismissed by physicians, awareness of the chronic symptoms has earned the attention of the National Institutes of Health, which has proposed “post-acute sequelae of SARS-CoV-2 infection (‘PASC’)” as an all-encompassing name for the malady.
Symptoms can range from chronic fatigue to cardiac conditions, highlighting the need for widespread adoption of simple and fast standards of care to monitor organs and tissue to best understand a patient’s condition. That’s exactly what upstart Mediscan Inc., a subsidiary of Healthtech Solutions (OTC: HLTT), is bringing to the table with its innovative software application that converts two-dimensional ultrasound images into a 3D, high-definition format in under one minute for immediate attention at the point of care.
Mediscan is bridging a big gap in healthcare today where access to magnetic resonance imaging (“MRI”) and computed tomography (CT or CAT) machines often aren’t readily available, much less convenient for immediate care. The poignant fact is that many of those facilities try to avoid even having COVID-positive patients on site—that goes without mentioning the high costs for those tests. An MRI in the U.S. in 2019 averaged $2,611, according to GE Healthcare citing Time Magazine (https://nnw.fm/lH7xB). CT scans can cost up to $3,275 (www.NewChoiceHealth.com).
Mediscan is looking to disrupt the $134 billion U.S. medical imaging market (https://nnw.fm/1eW20) with its cloud-based software that reconstructs an ultrasound’s analog 2D grayscale image into digital 3D HD format nearly instantly. For the first time, medical professionals will have at their fingertips images containing data-driven metrics that previously were only available through X-rays or MRI and CT scans. A video discussing the technology is available for viewing online (https://nnw.fm/u0r44).
Applications abound for the user-friendly technology, including a physician’s office, sporting facilities and events, isolation wards, emergency rooms and on-location for emergency medical services (“EMS”) personnel, to name a few. Anywhere an internet signal can be used – which is nearly everywhere anymore thanks to hot spots – once certified, the Mediscan technology will be able to provide almost immediate, actionable information on heart, lungs, tendons, skin and other organs. Furthermore, the Mediscan app integrates with all the popular electronic medical record (“EMR”) systems for comprehensive record keeping.
An opportunity is present for market penetration by utilizing the technology for PASC with any of the nearly 30 million Americans diagnosed with COVID-19 for an easy point-of-care diagnostic that is reliable and repeatable to track progression or regression without the inconvenience and high cost of legacy technologies. Once in the doctor’s office and other locations, it’s hard to imagine Mediscan not becoming an integral part of patient care, where a doctor or nurse could say, “Let’s take a closer look” and have data in a matter of minutes using only a portable ultrasound device and the Mediscan app.
For more information, visit the company’s website at www.MyMediScan.com.
NOTE TO INVESTORS: The latest news and updates relating to HLTT are available in the company’s newsroom at https://nnw.fm/HLTT
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(1)
(0)Healthtech Solutions Inc. (HLTT) Stock Research Links
Scroll down for more posts ▼